WellGenx Archives - LevinPro Healthcare M&A – The latest healthcare M&A news

Noom Acquires 503A Compounding Pharmacy Tailor Made Compounding

by Avery Swett | Apr 2, 2026 2:54 pm | Specialty Pharmacy
Weight-loss company Noom has acquired 503A pharmacy Tailor Made Compounding, according to an April 1 press release. Noom Tailor Made Compounding is a 503A pharmacy that provides sterile and non-sterile compounding through its pharmacy practice focused on aging. It offers compounded drugs, including hormone... Read More »
Premier Radiology Buys Teleradiology Group Global Imaging Solutions

by Avery Swett | Apr 2, 2026 2:32 pm | Laboratories, MRI & Dialysis, Private Equity
Premier Radiology Services announced the acquisition of Global Imaging Solutions, also called GLOBIS. Financial terms of the deal were not disclosed. Global Imaging Solutions, also called GLOBIS, is a teleradiology group providing subspecialty imaging interpretations to outpatient imaging centers and orthopedic practices and physician-owned... Read More »
Vision Innovation Partners Expands in Maryland

by Kate Humphrey | Mar 31, 2026 1:41 pm | Physician Medical Groups
Vision Innovation Partners (VIP) has expanded its Maryland presence with the acquisition of Frederick Eye Institute. Frederick Eye Institute, based in Frederick, Maryland, is a comprehensive ophthalmology practice. It specializes in cataract surgery and lens implants. The practice also employs the latest technology to provide care... Read More »
Citizens Advises Lync Health Partners on its Majority Recapitalization

by Avery Swett | Mar 31, 2026 12:28 pm | Outpatient Surgery Center
Citizens Capital Markets & Advisory has served as exclusive financial advisor to Lync Health Partners on its majority recapitalization by United Surgical Partners International. Citizens Capital Markets & Advisory is part of the institutional broker-dealer, Citizens JMP Securities, LLC, a subsidiary of Citizens Financial Group. Lync... Read More »
Eli Lilly to Acquire Centessa Pharmaceuticals for $6.3 Billion

by Avery Swett | Mar 31, 2026 12:26 pm | Biotechnology
Eli Lilly and Company announced on March 31 that it will be acquiring Boston- and London-based Centessa Pharmaceuticals. Centessa Pharmaceuticals is a clinical-stage pharmaceutical company developing a new class of drugs for the treatment of excessive daytime sleepiness and other neurological conditions. Centessa’s lead program... Read More »

Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40

Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121

WellGenx Merges with WaiveDx

by Kate Humphrey | Aug 28, 2025 3:38 pm | Laboratories, MRI & Dialysis

WellGenx and WaiveDx announced on August 26 the merger of the two companies. WellGenx, headquartered in San Antonio, Texas, delivers genetics-based solutions for anti-aging, wellness, longevity and behavioral health. In collaboration with the National Institutes of Health, National Human Genome Center and multiple academic centers, the company specializes in supplement and neuronutrient formulations, at-home testing and precision protocols driven by DNA and lab-based data. WaiveDx is an AI-driven healthcare technology company revolutionizing diagnostics through advanced platforms for laboratory operations, clinical decision support, data management and security and research... Read More »

Noom Acquires 503A Compounding Pharmacy Tailor Made Compounding

Premier Radiology Buys Teleradiology Group Global Imaging Solutions

Vision Innovation Partners Expands in Maryland

Citizens Advises Lync Health Partners on its Majority Recapitalization

Eli Lilly to Acquire Centessa Pharmaceuticals for $6.3 Billion

WellGenx Merges with WaiveDx

Schedule a demo

Categories

Archives

Irving Levin Associates LLC